<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02628990</url>
  </required_header>
  <id_info>
    <org_study_id>YD2005</org_study_id>
    <nct_id>NCT02628990</nct_id>
  </id_info>
  <brief_title>Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks</brief_title>
  <official_title>The Effect of Plant Stanol Ester Yoghurt Drinks With or Without Added Camelina Oil on Serum Lipids in Comparison to Placebo in Subjects With Mildly to Moderately Elevated Serum Cholesterol Concentrations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Raisio Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Raisio Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to investigate the effects of yoghurt drinks containing two doses of plant stanol
      ester either with or without added camelina oil on the serum cholesterol levels in moderately
      hypercholesterolemic subjects
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <primary_completion_date type="Actual">August 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentual change in serum LDL-cholesterol</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentual change [end of intervention - start of intervention] in serum LDL-cholesterol between experimental and placebo groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absolute change in serum LDL-cholesterol</measure>
    <time_frame>4 weeks</time_frame>
    <description>Absolute change [end of intervention - start of intervention] in serum LDL-cholesterol between experimental and placebo groups, mmol/l</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentual change in serum total cholesterol</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentual change [end of intervention - start of intervention] in serum total cholesterol between experimental and placebo groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absolute change in serum total cholesterol</measure>
    <time_frame>4 weeks</time_frame>
    <description>Absolute change [end of intervention - start of intervention] in serum total cholesterol between experimental and placebo groups, mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentual change in serum non-HDL cholesterol</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentual change [end of intervention - start of intervention] in serum nonHDL cholesterol between experimental and placebo groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absolute change in serum non-HDL cholesterol</measure>
    <time_frame>4 weeks</time_frame>
    <description>Absolute change [end of intervention - start of intervention] in serum nonHDL cholesterol between experimental and placebo groups, mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentual change in serum triglycerides</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentual change [end of intervention - start of intervention] in serum triglycerides between experimental and placebo groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absolute change in serum triglycerides</measure>
    <time_frame>4 weeks</time_frame>
    <description>Absolute change [end of intervention - start of intervention] in serum triglycerides between experimental and placebo groups, mmol/l</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">155</enrollment>
  <condition>Hypercholesterolemia</condition>
  <condition>Hyperlipidemias</condition>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>1.6 g plant stanols</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A yoghurt drink containing plant stanol ester (1.6 grams plant stanols), consumed with a meal daily for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 g plant stanols</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A yoghurt drink containing plant stanol ester (2 grams plant stanols), consumed with a meal daily for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1.6 g plant stanols and camelina oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A yoghurt drink containing plant stanol ester (1.6 grams plant stanols) and camelina oil (2 g), consumed with a meal daily for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 g plant stanols and camelina oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A yoghurt drink containing plant stanol ester (2 grams plant stanols) and camelina oil (2 g), consumed with a meal daily for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A placebo yoghurt drink, consumed with a meal daily for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>1.6 g plant stanols</intervention_name>
    <description>Lipid-lowering effect of Yoghurt Drink with 1.6 g plant stanols</description>
    <arm_group_label>1.6 g plant stanols</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2 g plant stanols</intervention_name>
    <description>Lipid-lowering effect of Yoghurt Drink with 2 g plant stanols</description>
    <arm_group_label>2 g plant stanols</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>1.6 g plant stanols and camelina oil</intervention_name>
    <description>Lipid-lowering effect of Yoghurt Drink with 1.6 g plant stanols and camelina oil</description>
    <arm_group_label>1.6 g plant stanols and camelina oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2 g plant stanols and camelina oil</intervention_name>
    <description>Lipid-lowering effect of Yoghurt Drink with 2 g plant stanols and camelina oil</description>
    <arm_group_label>2 g plant stanols and camelina oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Lipid-lowering effect of Placebo Yoghurt Drink</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &lt; 30 kg/m2

          -  moderate hypercholesterolemia (fasting total cholesterol between 5-8 mmol/l)

          -  serum triglycerides &lt; 3 mmol/l.

          -  normal liver, kidney and thyroid function

          -  subjects must voluntarily sign the informed consent

        Exclusion Criteria:

          -  use of cholesterol lowering foods or dietary supplements within 21 days before the
             start of the intervention

          -  lipid lowering medication

          -  history of unstable coronary artery disease (myocardial infarction, coronary artery
             bypass craft (CABG), percutaneous transluminal coronary angioplasty (PTCA) within the
             previous 6 months, diabetes, hyperglycemia, temporal ischemic attack and malignant
             diseases

          -  pregnancy or lactation

          -  alcohol abuse

          -  subjects with intolerance to any ingredient of the test products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <last_update_submitted>December 9, 2015</last_update_submitted>
  <last_update_submitted_qc>December 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

